These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3521264)

  • 21. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
    Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
    Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemia.
    Vellekoop L; Zander AR; Kantarjian HM; Jagannath S; Hester JP; Trujillo J; McCredie KB; Zagars G; Spitzer G; Dicke KA
    J Clin Oncol; 1986 Jun; 4(6):906-11. PubMed ID: 3519881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect on platelet increments of granulocyte-macrophage-colony-stimulating factor following autologous bone marrow transplantation for malignant lymphoma.
    Chambers LA; Garcia LW
    Transfusion; 1994 Mar; 34(3):221-5. PubMed ID: 8146894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.
    Bensinger W; Petersen FB; Banaji M; Buckner CD; Clift R; Slichter SJ; Storb R; Thomas ED
    Bone Marrow Transplant; 1989 Jul; 4(4):409-14. PubMed ID: 2673461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
    Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation.
    Hersman J; Meyers JD; Thomas ED; Buckner CD; Clift R
    Ann Intern Med; 1982 Feb; 96(2):149-52. PubMed ID: 6277215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow transplantation for chronic granulocytic leukemia.
    Lehn P; Devergie A; Benbunan M; Lemercier N; Raffoux C; Rabian C; Vilmer E; Azogui O; Irti T; Gluckman E
    J Natl Cancer Inst; 1986 Jun; 76(6):1301-5. PubMed ID: 3520072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic transplantation combining mobilized blood and bone marrow in patients with refractory hematologic malignancies.
    Nemunaitis J; Rosenfeld C; Collins R; Pallansch P; Piñeiro L; Ohr S; Waxman D; Stone M; Fay J; Miller W
    Transfusion; 1995 Aug; 35(8):666-73. PubMed ID: 7631407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
    Oza A; Hallemeier C; Goodnough L; Khoury H; Shenoy S; Devine S; Augustin K; Vij R; Trinkaus K; Dipersio JF; Adkins D
    Transfusion; 2006 Jan; 46(1):14-23. PubMed ID: 16398726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
    Biggs JC; Atkinson KA; Booker V; Concannon A; Dart GW; Dodds A; Downs K; Szer J; Turner J; Worthington R
    Bone Marrow Transplant; 1995 Jan; 15(1):129-34. PubMed ID: 7742745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation.
    Mathews V; George B; Lakshmi KM; Viswabandya A; John JM; Sitaram U; Daniel D; Chandy M; Srivastava A
    Pediatr Transplant; 2009 Mar; 13(2):171-6. PubMed ID: 18482210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posttransfusion purpura following bone marrow transplantation.
    Evenson DA; Stroncek DF; Pulkrabek S; Perry EH; Radford J; Miller JS; Verfaillie C
    Transfusion; 1995 Aug; 35(8):688-93. PubMed ID: 7631411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scintigraphy with indium-111-labeled homologous (donor) platelets in the platelet transfusion refractory bone marrow transplant patient.
    Hammersmith SM; Jacobson AF; Mankoff DA
    J Nucl Med; 1997 Jul; 38(7):1135-8. PubMed ID: 9225806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia.
    Schiffer CA; Aisner J; Dutcher JP; Wiernik PH
    Am J Hematol; 1983 Aug; 15(1):65-74. PubMed ID: 6576631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
    Demirer T; Gooley T; Buckner CD; Petersen FB; Lilleby K; Rowley S; Sanders J; Storb R; Appelbaum FR; Bensinger WI
    Bone Marrow Transplant; 1995 Jun; 15(6):907-13. PubMed ID: 7581090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splenectomy for poor graft function after allogeneic bone marrow transplantation in patients with chronic myeloid leukemia.
    Richard C; Romón I; Perez-Encinas M; Baro J; Rabuñal MJ; Mazorra F; Garcia de Polavieja M; Briz M; Ortin M; Iriondo A; Hermida G; Conde E; Bello JL; Zubizarreta A
    Leukemia; 1996 Oct; 10(10):1615-8. PubMed ID: 8847896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.